Fig. 3From: Frequency of EGFR T790M mutation and multimutational profiles of rebiopsy samples from non-small cell lung cancer developing acquired resistance to EGFR tyrosine kinase inhibitors in Japanese patientsRelationship of EGFR-TKI continuation beyond progressive disease and T790M prevalenceBack to article page